Mpox's Lessons on Pandemic Preparedness

Health Equity in Focus

For years, Africa grappled with a steady rise in mpox cases and recurring outbreaks, yet the disease remained largely overlooked by the global community. It was only when the virus reached Northern countries that mpox began to garner international attention. This long-standing neglect is evident in the sparse data on the disease, the minimal investment in research and development of medical countermeasures, delayed regulatory approvals, and stark inequities in access to these measures.
In this Health Equity in Focus episode, we welcome Chetali Rao, a senior researcher at the Third World Network and an expert in biotechnology, intellectual property, and global health to discuss the pressing ethical, legal, and equity issues raised by the global mpox response and the role the Pandemic Instrument, an agreement currently under negotiation at the WHO, could play.
Chetali provides an in-depth analysis of the current landscape of vaccines, therapeutics, and diagnostics, highlighting the stark inequities faced by developing countries in accessing these critical resources. She also examines the challenges of affordability, the monopolistic practices of manufacturers, and the consequences of relying on a few producers for lifesaving medical countermeasures. Finally, she addresses what could be a potential response to these issues, the Pathogens Access and Benefit Sharing System being negotiated at the WHO.
To clarify the complexities of mpox outbreaks and developments, we have created a timeline that traces the virus’s emergence and trends, focusing on 2022 and 2024. It highlights the deployment of vaccines, therapeutics, and diagnostics, while exposing inequalities in access and Africa’s long-standing burden.
Transcripts in English and Spanish.

Credits
Production: Third World Network Berhad
Audio editing: Guilherme Conde
Soundtrack: Daniel Gómez Rico
Artwork: Ames Sia